The first universal molecular diagnostic for the qualitative detection of all clades of Crimean-Congo hemorrhagic fever virus (CCHFV).

Aldatu’s PANDAA technology is a unique adaptive PCR approach that mitigates the inter-clade genomic diversity of Crimean-Congo hemorrhagic fever virus (CCHFV), where other PCR approaches cannot, to provide the first universal real-time PCR assay for the qualitative detection of CCHFV RNA. Questions? Email


  • The only assay for universal pan-clade detection of the Crimean-Congo hemorrhagic fever virus
  • Fast – delivers accurate results from RNA in 1 hour
  • One of the most sensitive CCHFV molecular diagnostics available, with a limit of detection 10 copies / reaction.
  • Platform-agnostic – compatible with most sample prep and qPCR platforms.

For research use only (RUO). Not for use in diagnostic procedures.

Additional information

Kit Size

96 reactions [20 µL]



Order Inquiry


For Research Use Only. This test has not been cleared or approved by the U.S. Food and Drug Administration (FDA). This product is covered by one or more patents, trademarks and / or copyrights owned or controlled by Aldatu Biosciences, Inc.

PANDAA primer and probe designs are proprietary to Aldatu Biosciences.

User Guide

Kit Contents

Performance Summary


User guides and protocols